Michael Petusky
Stock Analyst at Barrington Research
(2.15)
# 2,882
Out of 4,983 analysts
196
Total ratings
38.15%
Success rate
-3.39%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRME VerifyMe | Maintains: Outperform | $1.25 → $1.5 | $0.84 | +77.62% | 10 | Aug 14, 2025 | |
| SRDX Surmodics | Reiterates: Market Perform | n/a | $31.91 | - | 7 | Aug 11, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $21 → $18 | $13.62 | +32.16% | 23 | Aug 8, 2025 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $98 → $103 | $78.44 | +31.31% | 24 | Aug 8, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $95 → $86 | $51.02 | +68.56% | 30 | Aug 8, 2025 | |
| LMAT LeMaitre Vascular | Upgrades: Outperform | $95 | $92.45 | +2.76% | 11 | Aug 6, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $86 → $78 | $68.39 | +14.05% | 15 | Aug 6, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $103 | $82.69 | +24.56% | 21 | Jul 31, 2025 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $19 → $15 | $8.65 | +73.41% | 18 | Jul 31, 2025 | |
| OPCH Option Care Health | Maintains: Outperform | $38 | $27.56 | +37.88% | 16 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $14.84 | +7.82% | 1 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $2.25 | $1.39 | +61.87% | 14 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.86 | - | 6 | Aug 28, 2024 |
VerifyMe
Aug 14, 2025
Maintains: Outperform
Price Target: $1.25 → $1.5
Current: $0.84
Upside: +77.62%
Surmodics
Aug 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $31.91
Upside: -
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Outperform
Price Target: $21 → $18
Current: $13.62
Upside: +32.16%
U.S. Physical Therapy
Aug 8, 2025
Maintains: Outperform
Price Target: $98 → $103
Current: $78.44
Upside: +31.31%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $95 → $86
Current: $51.02
Upside: +68.56%
LeMaitre Vascular
Aug 6, 2025
Upgrades: Outperform
Price Target: $95
Current: $92.45
Upside: +2.76%
Henry Schein
Aug 6, 2025
Maintains: Outperform
Price Target: $86 → $78
Current: $68.39
Upside: +14.05%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $103
Current: $82.69
Upside: +24.56%
Anika Therapeutics
Jul 31, 2025
Maintains: Outperform
Price Target: $19 → $15
Current: $8.65
Upside: +73.41%
Option Care Health
Jul 10, 2025
Maintains: Outperform
Price Target: $38
Current: $27.56
Upside: +37.88%
Jun 23, 2025
Initiates: Outperform
Price Target: $16
Current: $14.84
Upside: +7.82%
May 1, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.39
Upside: +61.87%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $7.86
Upside: -